Vision for a versatile nanodevice for early-stage disease and cancer diagnostics [ 2019 - ]

Research Grant

Researchers: Dr Kang Liang (Principal investigator)

Brief description This project aims to develop the next generation diagnostic nanodevice for early-stage disease and cancer detection with high sensitivity and specificity. Utilising the newly developed antibody engineering technology, this nanodevice will be a versatile and cost-effective solution to almost any disease associated biomarker detection. It intends to address the unmet clinical need for more effective and generalizable disease detection and to accurately evaluate and monitor treatments.

Funding Amount $437,036.00

Funding Scheme Career Development Fellowships

Notes RD Wright Biomedical CDF